Featured Stories

2014 SoftFocus® Compound Libraries


For 15 years, SoftFocus compound libraries have pioneered the field of rationally designed focused libraries, with a new range of novel libraries designed and released each year. We are pleased to announce the completion of the 2014 collection, comprising over 30 libraries.

Expanded Immunology Services


Our Edinburgh site has just moved its cell-based assay work into new laboratory facilities and has been developing new approaches in neutralizing antibody (NAb) and antibody-dependent cell-mediated cytotoxicity (ADCC) assays.

Translational Asthma In Vivo Models


With the acquisition of Argenta earlier this year, Charles River's asthma expertise and portfolio has expanded to include unique models that reflect the clinical setting.

Charles River to Maintain the Frederick NCI Facility


As of today, Charles River will assume management and operational responsibilities for the Frederick facility and we will continue to breed and maintain the colonies that are currently housed at this facility.

Charles River Acquires VivoPath to Deepen Discovery Expertise


Our recent acquisition of VivoPath, a Massachusetts-based discovery CRO, along with the March 2014 acquisition of Argenta and BioFocus, has positioned Charles River as an industry leader in offering discovery services to the biopharmaceutical industry. 

Displaying results 1-10 (of 120)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|